Anti-Human FCGR3B Antibody [A1052]
Anti-Human FCGR3B Antibody [A1052] with collaborator-tested evidence for IHC-P. Read more ›
["IHC-P"]![Anti-Human FCGR3B Antibody [A1052]](http://www.abmium.com/cdn/shop/files/Screenshot_2026-06-08_210431_3df9d005-1ce0-4f3f-9bc1-fdc9548fb552.png?v=1781049938&width=160)
Product Description
FCGR3B is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Mouse; clonality: Monoclonal; clone: A1052; isotype: IgG1; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC-P. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human CD16b/FCGR3B Protein; purification: Protein A; concentration: 1 mg/mL.
Database references: UniProt: O75015.
Research Use Only.
Key Facts
| Target | FCGR3B |
| Also known as | FCG, FCR, Fcgr, IgG Fc receptor III, IGFR, FCGR3B, CD16, CD16b, FCG3, FCGR3, FCR-10, FCRIII, FCRIIIb, CD16b and FCGR3B, CD16b and FCGR4B, CD16b and FCGR5B, CD16b and FCGR6B, Fc-gamma RIII-beta, IgG Fc receptor III-1, Low affinity immunoglobulin gamma Fc region receptor III-B, IGFR3, Fc&, gamma-RIIIB-B, CD16A, Fc fragment of IgG receptor IIIb, FCGR3A |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Immunology |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.